7-141973041-T-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_176817.5(TAS2R38):āc.649A>Cā(p.Thr217Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000576 in 1,613,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_176817.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAS2R38 | NM_176817.5 | c.649A>C | p.Thr217Pro | missense_variant | 1/1 | ENST00000547270.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAS2R38 | ENST00000547270.1 | c.649A>C | p.Thr217Pro | missense_variant | 1/1 | NM_176817.5 | P1 | ||
MGAM | ENST00000465654.5 | c.-3+27044T>G | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152004Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251260Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135808
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461870Hom.: 0 Cov.: 62 AF XY: 0.0000316 AC XY: 23AN XY: 727234
GnomAD4 genome AF: 0.000243 AC: 37AN: 152122Hom.: 0 Cov.: 31 AF XY: 0.000323 AC XY: 24AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2023 | The c.649A>C (p.T217P) alteration is located in exon 1 (coding exon 1) of the TAS2R38 gene. This alteration results from a A to C substitution at nucleotide position 649, causing the threonine (T) at amino acid position 217 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at